September 15, 2023

House law­mak­ers have re­turned from re­cess with their work cut out for them to ad­dress on­go­ing drug short­ages, but reach­ing bi­par­ti­san con­sen­sus on how to

The fed­er­al gov­ern­ment has re­leased the lat­est round of Medicare coin­sur­ance sav­ings un­der the In­fla­tion Re­duc­tion Act’s re­bate pro­gram. The leg­is­la­tion en­act­ed last sum­mer re­quires

A 2016 class ac­tion law­suit filed against Alex­ion claim­ing shady sales prac­tices caused a de­cline in stock price could be near­ing its end af­ter both

Re­gen­eron wants old­er adults to start do­ing month­ly vi­sion checks at home, and it’s en­list­ing ac­tor and dancer Deb­bie Allen to help lead the way.

South Africa’s Com­pe­ti­tion Com­mis­sion is set to probe John­son & John­son amid claims that the Big Phar­ma is charg­ing the na­tion more than dou­ble than

The Fed­er­al Trade Com­mis­sion vot­ed 3-0 on Thurs­day to is­sue a pol­i­cy state­ment to in­crease scruti­ny of im­prop­er list­ing of patents in the FDA’s Or­ange

John­son & John­son is drop­ping the name Janssen for its phar­ma­ceu­ti­cal di­vi­sion and adopt­ing a con­tem­po­rary vi­su­al iden­ti­ty as part of a brand up­date an­nounced